June 26, 2024 02:51 PM EDT
Deals
Pharma

Ha­le­on to sell nico­tine re­place­ment ther­a­py busi­ness to Dr. Red­dy’s for $630M

Lia DeGroot

Ha­le­on has agreed to sell its ex-US nico­tine re­place­ment ther­a­py busi­ness to Dr. Red­dy’s for a to­tal of £500 mil­lion, or about $630 mil­lion, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times